ADVFN US – Market Content Editor
-
Corcept shares soar after FDA approves relacorilant cancer treatment
Shares of Corcept Therapeutics (NASDAQ:CORT) surged about 40% on Wednesday after the U.S. Food and Drug Administration (FDA) approved relacorilant (Lifyorli) in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The approval covers patients who have previously undergone one to three systemic treatment regimens, including…
-
Chewy shares jump after strong fourth-quarter earnings beat
Shares of Chewy Inc. (NYSE:CHWY) climbed about 10% in premarket trading after the online pet retailer reported fourth-quarter results that topped analyst expectations. The company posted adjusted earnings per share of $0.27, exceeding the analyst consensus of $0.09 by $0.18. Quarterly revenue totaled $3.26 billion, in line with forecasts and marking 8.1% growth on a…
-
SentinelOne shares rise after expanded Google Cloud security partnership
Shares of SentinelOne (NYSE:S) climbed about 2% on Wednesday after the cybersecurity company announced an expanded multi-year strategic partnership with Google Cloud aimed at developing integrated security solutions. The collaboration will combine SentinelOne’s endpoint detection and response technology and AI-native security platform with Google Cloud’s infrastructure and threat intelligence capabilities. The companies said the initiative…
-
Bunge shares slip after short seller calls for accounting probe
Shares of Bunge Global SA (NYSE:BG) declined more than 2% in premarket trading Wednesday after short-selling firm Spruce Point Management released a report urging an independent investigation into the company’s accounting practices and financial disclosures. Spruce Point published what it described as a forensic analysis of the agribusiness group, arguing that the S&P 500 constituent…
-
Sarepta shares jump after early clinical data from siRNA programs
Shares of Sarepta Therapeutics (NASDAQ:SRPT) climbed about 14% after the company released preliminary clinical results from its siRNA-based pipeline targeting facio scapulo humeral muscular dystrophy type 1 (FSHD1) and myotonic dystrophy type 1 (DM1). The Cambridge, Massachusetts-based biotechnology company reported early findings from Phase 1/2 ascending-dose studies evaluating SRP-1001 for FSHD1 and SRP-1003 for DM1.…
-
Dell unveils redesigned commercial PC portfolio with built-in AI features
Dell Technologies (NYSE:DELL) has introduced a revamped lineup of commercial computing products, including Dell Pro notebooks, Dell Pro Precision workstations, desktops, monitors, and peripherals, the company said in a statement. The new Dell Pro notebook family features systems powered by Intel Core Ultra Series 3 processors and AMD Ryzen AI 400 chips, designed to support…
-
Freshpet shares edge higher as analysts downplay competitive concerns
Shares of Freshpet (NASDAQ:FRPT) rose modestly in premarket trading Monday, gaining about 63 basis points, after analysts at DA Davidson reiterated a Buy rating on the stock and downplayed concerns about new competition in the fresh pet food market. The stock had recently come under pressure following reports that The Farmer’s Dog plans to launch…
-
Beyond Meat delays 2025 results filing to March 31 amid accounting review
Beyond Meat Inc. (NASDAQ:BYND) said it will delay the release of its fourth-quarter and full-year 2025 financial results until March 31, 2026, as the company works to complete its financial closing process and address weaknesses in its internal accounting controls. The plant-based food producer disclosed a material weakness in its internal control over financial reporting…
-
Intel shares rise after report of planned CPU price increases
Shares of Intel Corporation (NASDAQ:INTC) climbed about 4% on Wednesday, while Advanced Micro Devices (NASDAQ:AMD) advanced roughly 2.5%, following a report that both companies have notified customers of upcoming price increases for their central processing units. According to Nikkei Asia, Intel and AMD have informed clients that they intend to raise prices across their entire…
-
Honeywell, Lockheed Martin shares edge higher following new defense agreements
Shares of Honeywell (NYSE:HON) rose about 1.3% to nearly $225 in premarket trading on Wednesday, while Lockheed Martin (NYSE:LMT) gained roughly 0.4% to around $613. Honeywell Aerospace announced that it has entered into a supplier framework agreement with the U.S. Department of War, supported by a multi-year $500 million investment aimed at expanding defense manufacturing…